Evidence map›Paper›PMID 30811346›Full record

ArticleAging2019

Alzheimer's disease as a multistage process: an analysis from a population-based cohort study.

Silvan Licher, Kimberly D van der Willik, Elisabeth J Vinke, Pinar Yilmaz, Lana Fani, Sanne B Schagen, M Arfan Ikram, M Kamran Ikram

Abstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Silvan LicherDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
Kimberly D van der WillikDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
Elisabeth J VinkeDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
Pinar YilmazDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
Lana FaniDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
Sanne B SchagenDepartment of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
M Arfan IkramDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
M Kamran IkramDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In cancer research, multistage models are used to assess the multistep process that leads to the onset of cancer. In view of biological and clinical similarities between cancer and dementia, we used these models to study Alzheimer's disease (AD). From the population-based Rotterdam Study, we included 9,362 non-demented participants, of whom 1,124 developed AD during up to 26 years of follow-up. Under a multistage model, we regressed the logarithm of AD incidence rate against the logarithm of five-year age categories. The slope in this model reflects the number of steps (n-1) required for disease onset before the final step leading to disease manifestation. A linear relationship between log incidence rate and log age was observed, with a slope of 12.82 (95% confidence interval: 9.01-16.62), equivalent to 14 steps. We observed fewer steps for those at high genetically determined risk: 12 steps for

Indexed as

Genetic Predisposition to DiseaseAgedAgingAlzheimer DiseaseApolipoproteins ECohort StudiesFemaleHumansMaleMiddle AgedModels, BiologicalTime FactorsApolipoproteins EAlzheimer’s diseaseAPOEepidemiologygenetic risk scoregenetics

Identifiers

PMID30811346
PMCPMC6402512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.